Aquinox Pharmaceuticals
About:
Aquinox Pharmaceuticals develops and commercializes small molecule therapeutics for the treatment of cancer and inflammatory diseases.
Website: http://www.aqxpharma.com
Twitter/X: aqxpharma
Top Investors: Cowen Group, Pfizer Venture Investments, Johnson & Johnson Development Corporation, Baker Brothers Advisors LLC, Ventures West
Description:
Aquinox Pharmaceuticals Inc., a pharmaceutical company, engages in discovery, development, and commercialization of small molecule therapeutics for the treatment of cancer and inflammatory disease. It offers AQX-MN100, a drug used to treat cancer and inflammatory disease, as well as SH2-containing inositol 5'-phosphatase inhibition program for blood cell recovery. The company was founded in 2004 and is based in Vancouver, Canada.
$221M
$10M to $50M
Vancouver, British Columbia, Canada
2004-01-01
info(AT)aqxpharma.com
11-50
2016-09-20
Public
© 2025 bioDAO.ai